| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/22/2012 | CN101843848B 一种治疗痛风的中药组合物 A method of treating gout medicine composition |
| 02/22/2012 | CN101816705B 三针注射及熏蒸治疗股骨头坏死的药物及制备方法 Three injections and drug fumigation treatment of femoral head necrosis and preparation methods |
| 02/22/2012 | CN101785757B 一种紫杉醇自乳化制剂及其制备方法和用途 One of paclitaxel self-emulsifying formulation and preparation method and uses |
| 02/22/2012 | CN101779886B 一种颈椎保健枕、枕套及药袋 One kind Cervical Pillow, pillowcase and Irazu |
| 02/22/2012 | CN101757450B 一种治疗骨病的膏药 A method of treating bone disease plaster |
| 02/22/2012 | CN101757322B 一种治疗痛风性关节炎的植物药复方制剂及其制备和应用 A method of treating gouty arthritis herbal compound and its preparation and application |
| 02/22/2012 | CN101700331B 接骨灵喷雾剂 Bone Spirit sprays |
| 02/22/2012 | CN101668516B 具有改善的维生素d含量均匀度的药物剂型 Vitamin d having improved uniformity of the contents of the pharmaceutical dosage form |
| 02/22/2012 | CN101524458B 土茯苓皂甙、黄酮类提取物及其制备方法 Smilax saponins, flavonoids extract and its preparation method |
| 02/22/2012 | CN101502629B 一种治疗系统性红斑狼疮的中药复方制剂 A method of treating systemic lupus erythematosus traditional Chinese medicine |
| 02/21/2012 | US8119798 P38 kinase inhibitors |
| 02/21/2012 | US8119687 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 02/21/2012 | US8119665 Aryl imidazoles and related compounds as C5a receptor modulators |
| 02/21/2012 | US8119648 Arthritis, obesity, (non-insulin dependent) diabetes calcitonin-induced osteoporosis; administering allograft transplantation; dipeptidyl peptidase-IV (DPP-IV) inhibitors |
| 02/21/2012 | US8119631 Inhibitors of interleukin-1β converting enzyme |
| 02/21/2012 | US8119604 Polypeptide formulation |
| 02/21/2012 | US8119397 Therapeutic agents and therapeutic methods for treating injured tissue |
| 02/21/2012 | US8119121 Delivering a concentrated amount of stem cells obtained from adipose tissue to a patient |
| 02/21/2012 | CA2650399C Gpr119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto |
| 02/21/2012 | CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors |
| 02/21/2012 | CA2451981C 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 02/21/2012 | CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2012 | CA2386506C Isolation of precursor cells and their use for tissue repair |
| 02/21/2012 | CA2349760C Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors |
| 02/16/2012 | WO2012021778A2 Methods for blocking cell proliferation and treating diseases and conditions responsive to cell growth inhibition |
| 02/16/2012 | WO2012020762A1 Hetero ring compound |
| 02/16/2012 | WO2012020272A2 New salts, polymorphs and solvates of a pharmaceutical active ingredient |
| 02/16/2012 | WO2012020072A1 Anti-syndecan-4 antibodies |
| 02/16/2012 | WO2012020021A1 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases |
| 02/16/2012 | WO2012007632A9 Use of edg2 inhibitors for treating rheumatoid arthritis |
| 02/16/2012 | WO2011126833A3 Anti-inflammatory factors |
| 02/16/2012 | US20120041524 Compositions for Providing Vitamin D Year Round and Uses Thereof |
| 02/16/2012 | US20120041054 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction |
| 02/16/2012 | US20120041045 Use of pharmaceutical compositions containing mesembrenone |
| 02/16/2012 | US20120041031 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists |
| 02/16/2012 | US20120041024 Quinolyl amines as kinase inhibitors |
| 02/16/2012 | US20120040999 P38 kinase inhibiting agents |
| 02/16/2012 | US20120040997 Vinyl-aryl derivatives for inflammation and immune-related uses |
| 02/16/2012 | US20120040993 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them |
| 02/16/2012 | US20120040987 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors |
| 02/16/2012 | US20120040983 Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof |
| 02/16/2012 | US20120040982 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 02/16/2012 | US20120040964 N-substituted piperidines and their use as pharmaceuticals |
| 02/16/2012 | US20120040961 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders |
| 02/16/2012 | US20120040956 Inhibitors of hif-1 protein accumulation |
| 02/16/2012 | US20120040951 Heteroaryl compounds useful as raf kinase inhibitors |
| 02/16/2012 | US20120040936 Cyclic compound having substituted phenyl group |
| 02/16/2012 | US20120040935 Compositions useful as inhibitors of voltage-gated ion channels |
| 02/16/2012 | US20120040929 Food composition comprising glucosamine |
| 02/16/2012 | US20120040923 Stable s-adenosyl-l-methionine |
| 02/16/2012 | US20120040920 Oligosaccharide aldonic acids and their topical use |
| 02/16/2012 | US20120040908 Fracture repair promoter |
| 02/16/2012 | US20120040907 Method of Use of Bioactive Materials |
| 02/16/2012 | US20120040897 Novel derivatives of acyl cyanopyrrolidines |
| 02/16/2012 | US20120040015 Biocompatible composite and its use |
| 02/16/2012 | US20120040012 Therapeutic stem cell nutrient composition and uses thereof |
| 02/16/2012 | US20120040002 Resorbable and biocompatible fibre glass compositions and their uses |
| 02/16/2012 | US20120040000 Peptide pharmaceutical for oral delivery |
| 02/16/2012 | US20120039961 Implant and therapeutic composition for treating damage and/or diseases relating to the human animal musculoskeletal system |
| 02/16/2012 | US20120039946 Immunopotentiating composition and process for producing same |
| 02/16/2012 | US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor |
| 02/16/2012 | US20120039912 Rspondin-3 inhibition in bone disorders |
| 02/16/2012 | US20120039911 Cd93 or use of soluble fragment thereof |
| 02/16/2012 | US20120039883 Detection and diagnosis of inflammatory disorders |
| 02/16/2012 | US20120039873 Antibodies against monocyte chemotactic proteins |
| 02/16/2012 | US20120039867 Immune System Function in Conditions Characterized by Elevated Double Strand Breaks |
| 02/16/2012 | US20120039866 Methods of treating pain |
| 02/16/2012 | US20120039862 Extended Length Botulinum Toxin Formulation for Human or Mammalian Use |
| 02/16/2012 | US20120039841 T-Helper Cell Type 17 Lineage-Specific Adjuvants, Compositions and Methods |
| 02/16/2012 | US20120039840 Use of IL-27-P28 to antagonize IL-6 mediated signaling |
| 02/16/2012 | US20120039804 Novel Tricyclic Modulators of Cannabinoid Receptors |
| 02/16/2012 | US20120039801 SPARC binding peptides and uses thereof |
| 02/16/2012 | CA2808435A1 Heterocyclic compound |
| 02/16/2012 | CA2807051A1 Besylate salt of a btk inhibitor |
| 02/15/2012 | EP2418271A2 Methods and compositions for treatment of bone defects with placental cell populations |
| 02/15/2012 | EP2418203A1 Cyclic compound having substituted phenyl group |
| 02/15/2012 | EP2416803A1 New methods for treatment of inflammatory diseases |
| 02/15/2012 | EP2416767A2 Compositions and methods for bioactive coatings to improve allograft incorporation |
| 02/15/2012 | EP2416756A2 Stable pharmaceutical compositions with high bioavailibility |
| 02/15/2012 | EP2124944B1 Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors |
| 02/15/2012 | EP1831199B1 MMP inhibitors |
| 02/15/2012 | CN1918127B 具有引入了取代或无取代氨基的4-吡啶基烷硫基的环状化合物 The introduction of a cyclic compound having a substituted or unsubstituted 4-pyridyl amino alkylthio |
| 02/15/2012 | CN102351958A Preparation method and application of astragalus polysaccharide-calcium complex |
| 02/15/2012 | CN102351918A Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| 02/15/2012 | CN102351888A Mangiferin aglycon medicinal complex and preparation method and applications thereof |
| 02/15/2012 | CN102351880A Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors |
| 02/15/2012 | CN102351835A Mangiferin aglycone crystal forms, and composition, preparation method and application thereof |
| 02/15/2012 | CN102351732A Nuclear receptor binding agents |
| 02/15/2012 | CN102349989A Traditional Chinese medicine for treating cervical spondylosis |
| 02/15/2012 | CN102349967A Traditional Chinese medicine preparation for treating chronic cervical vertigo |
| 02/15/2012 | CN102349939A Saussurea involucrate extractive microemulsion compound |
| 02/15/2012 | CN102349938A Saussurea involucrate extractive carrier compound and preparation method thereof |
| 02/15/2012 | CN102349929A Drug for treating and preventing fracture |
| 02/15/2012 | CN102349887A Diclofenac sodium acetaminophen gastrointestinal type capsule medicinal composition |
| 02/15/2012 | CN102119973B 一种栀子渗漉液质量控制方法 One kind of gardenia percolate quality control methods |
| 02/15/2012 | CN102008564B 一种治疗骨质增生及酸痛的外用药 An external osteoarthritis and pain medication treatment |
| 02/15/2012 | CN101948464B 3,4,6-三芳基-[1,3]-噁嗪-2-酮类化合物、其制备方法和用途 3,4,6-triaryl - [1,3] - oxazin-2-ones compounds, their preparation and use |
| 02/15/2012 | CN101934024B 一种治疗强直性脊柱炎的灵仙蛇蝎膏药 A method for treating ankylosing spondylitis Ling Xian viper plaster |
| 02/15/2012 | CN101904953B 一种抗炎镇痛药物组合物及其制备方法和用途 An anti-inflammatory analgesic composition and preparation method and uses |
| 02/15/2012 | CN101850065B 一种治疗痛风的中药组合物 A method of treating gout medicine composition |